Over the past six months, our Founder and Global President Raman Sehgal has conducted over 50 interviews with some of the most senior (and well-respected) leaders in the pharmaceutical and biotech industry’s outsourcing segment.

In the latest episode of molecule to market, host Raman shares the top ten trends he expects to see in the industry, based on insights collated from the industry experts he’s had the pleasure of speaking with during 2020. In this guide, we explore these trends.

What lies ahead for the global pharma and biotech industry’s contract services industry in 2021 and beyond?